WFH closely monitoring Shire and Roche/Genentech patent dispute

The World Federation of Hemophilia has been closely monitoring the developing situation between Shire and Roche/Genentech and their dispute over patent ownership.  We will continue to do so and to inform our community of any developments as they become public.

In this situation, the WFH is concerned that all parties involved will not be able to resolve their dispute and ensure that access to treatment is not affected.

We will be sharing all information distributed by both parties.

To read the statements from Shire, please click here (Dec 14, 2017) and here (Jan 16, 2018) . To read the statement from Roche/Genentech click here (January 11, 2018).